Bryan Giraudo - 16 Sep 2021 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
COO/CFO
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
16 Sep 2021
Net transactions value
$0
Form type
4
Filing time
20 Sep 2021, 16:25:02 UTC
Previous filing
28 May 2021
Next filing
10 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 16 Sep 2021 Common Stock 150,000 $10.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the option will vest on September 16, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date